Healthcare, Pharma & Life Sciences

PRC-Saltillo Launches Genesis AAC Devices, Shipping in October

Image
PRC-Saltillo Launches Genesis AAC Devices, Shipping in October

Wooster, Ohio – September 17, 2026 -- PRC-Saltillo has launched its Genesis product line globally, introducing two Windows-based augmentative and alternative communication (AAC) devices for individuals with acquired or long-term complex communication needs, including ALS and cerebral palsy.

Genesis debuts in two screen sizes with expanded access options

The line launches with the 13-inch Genesis 13 and 16-inch Genesis 16, both built on 60 years of engineering, clinical, linguistic, and communicator expertise, according to the company. The devices feature vibrant displays, a three-inch angled partner display, customizable quick-access controls, front- and rear-facing surround audio, a multi-angle kickstand, larger power and volume buttons, extended battery life, and increased storage capacity.

RBS to Vet New Partners for Anoma Cancer Collective at ASTRO 2026

Nashville – September 17, 2026 -- Radiation Business Solutions (RBS) will meet with prospective partner organizations at the American Society for Radiation Oncology (ASTRO) Annual Meeting as part of a limited expansion phase for the Anoma Cancer Collective (ACC), a nonprofit foundation supporting community cancer care.

ACC currently backs cancer centers across five states

ACC supports community cancer programs in Alabama, Texas, Florida, Georgia and Oklahoma, and is evaluating a select number of additional markets for expansion. The organization operates as a nonprofit foundation financed through the bond market rather than through traditional acquisition capital.

Nutramax Doubles Veterinary CE Conference After 2,000+ Sign-Ups

Lancaster, S.C. – September 17, 2026 -- Nutramax Laboratories is splitting its flagship veterinary continuing education event into two annual conferences after registration for its 2026 gathering topped 2,000 attendees, a record for the program.

Nutramax expands A Different Way to CETM to fall and spring events

The company will hold a fall conference at the Gaylord Opryland Resort and Convention Center in Nashville, Tennessee, from Oct. 17-20, 2027, followed by a spring conference at the Gaylord Palms Resort and Convention Center in Orlando, Florida, from April 23-26, 2028. Both events will offer veterinary professionals up to 20 CE credits across more than 100 sessions, with meals included and a dedicated kids' zone for attending families.

Outcomes4Me Hires OpenEvidence Veteran Jim Longley as Chief Revenue Officer

Boston – September 17, 2026 -- Outcomes4Me Inc. has appointed Jim Longley, formerly Senior Vice President of AI Partnerships at OpenEvidence, as its new Chief Revenue Officer to lead commercial expansion across pharma, provider, and diagnostic partnerships.

Longley brings two decades of health tech revenue scaling to the role

Before OpenEvidence, Longley spent nearly five years at GoodRx, rising to Senior Vice President and Head of Commercial, and prior to that spent over six years at Doximity as Vice President for Business Development and Product Innovation. Outcomes4Me CEO Maya R. Said, Sc.D., said Longley has a track record of scaling health tech companies to hundreds of millions of dollars in revenue.

Notable Names Dr. Nicholas Desai Chief Medical Officer

Image
Notable Names Dr. Nicholas Desai Chief Medical Officer

San Mateo – September 17, 2026 -- Notable, a healthcare AI platform provider deployed at more than 12,000 sites of care, has appointed Dr. Nicholas Desai as Chief Medical Officer, tapping a former Houston Methodist executive to bridge enterprise technology and hospital operations.

Desai brings two decades of dual clinical and operations leadership from Houston Methodist

Desai joins Notable from Houston Methodist, where he held roles as system Chief Medical Information Officer and hospital Chief Operating Officer, Chief Medical Officer, and Chief Quality Officer. He most recently helped lead the development, opening, and growth of Houston Methodist Cypress Hospital, overseeing culture, clinical operations, and technology from the outset. His background spans more than 20 years connecting enterprise technology with clinical practice, with accountability for technology, people, growth, quality, and financial performance.

NUS Magnetic Pulse Therapy Eradicates Tumors in 75% of Preclinical Trials

Singapore – September 17, 2026 -- Researchers at the National University of Singapore (NUS) have eradicated tumours in 75 per cent of tested preclinical models using pulsed electromagnetic fields (PEMFs) alone, without chemotherapy, after just four 30-minute sessions. The study, led by Associate Professor Alfredo Franco-Obregón of the NUS Yong Loo Lin School of Medicine, was published in the journal Smart Medicine on September 17, 2026.

PEMF device already cleared Phase 1 human safety trials

The same PEMF device used in the study has completed Phase 1 clinical trials, confirming its safety in humans. The NUS team is now seeking partners to fund and conduct Phase 2 efficacy trials to evaluate treatment performance in patients.

Kelun-Biotech's HER2 ADC Beats T-DM1 in Phase III, Wins China Approval

Image
Kelun-Biotech's HER2 ADC Beats T-DM1 in Phase III, Wins China Approval

Chengdu – September 17, 2026 -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6990.HK) said phase III results for its HER2-targeted antibody-drug conjugate trastuzumab botidotin have been published in the Journal of Clinical Oncology, a journal with an impact factor of 44.7, after the drug outperformed Roche's trastuzumab emtansine (T-DM1) in a head-to-head trial and secured approval from China's National Medical Products Administration.

Montana Hospital Builds Homegrown Workforce Pipeline to Fight Rural Nursing Shortage

Image
Montana Hospital Builds Homegrown Workforce Pipeline to Fight Rural Nursing Shortage

Scobey, Montana – September 17, 2026 -- Daniels Memorial Healthcare Center, a full-service rural hospital in northeast Montana, is expanding a student-to-employee training pipeline as it plans a new hospital facility to counter chronic nursing shortages in frontier communities. The 1952-founded facility will be featured in an upcoming segment of the Public Television series "All Access hosted by Andy Garcia," which examines how local workforce development sustains emergency and primary care access in isolated regions.

Abe Yoando Pharma Chief First Japanese Speaker at Swiss Longevity Summit

Gstaad – September 17, 2026 -- Tomonari Abe, President of 295-year-old Abe Yoando Pharma Co., Ltd., has become the first Japanese speaker in the history of the Longevity Investors Conference, running September 14-17, 2026 in Gstaad, Switzerland.

Global longevity market poised to hit $8 trillion by 2030

The healthy longevity sector is projected to reach approximately $8 trillion by 2030, according to a UBS Chief Investment Office research report cited by the company. International investors are increasingly focused on Japan's aging population as a testing ground for longevity science and market validation ahead of other nations.

Intuitive Wins CE Mark for da Vinci SP Vaginal Surgery Use

Image
Intuitive Wins CE Mark for da Vinci SP Vaginal Surgery Use

Aubonne – September 17, 2026 -- Intuitive has secured CE mark approval for its da Vinci SP surgical system to perform transvaginal gynecologic procedures, marking the first such indication for the Single Port platform anywhere in the world.

Approval widens da Vinci SP's European surgical scope beyond five existing categories

The new indication adds to da Vinci SP's current CE-marked applications in Europe, which cover endoscopic abdominopelvic, thoracoscopic, transoral otolaryngology, transanal colorectal, and breast procedures. The system now supports natural orifice surgery across transoral, transanal, and transvaginal routes.